Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Megan Brooks

    News

    Surviving to Thriving: Enhancing Quality of Life in Breast Cancer

    Author:
    Megan Brooks
    Publish date: June 17, 2024

    Up to 90% of early breast cancer survivors experience long-term effects from treatment, which often include fatigue, loss of mobility, chronic...

    • Read More

    News

    Better Sleep Tied to Less Loneliness

    Author:
    Megan Brooks
    Publish date: June 17, 2024

    “Social awareness and social initiation would appear to be affected by sleep quality, therefore potentially leading, at least in part, to...

    • Read More

    News

    FDA OKs Iqirvo, First-in-Class PPAR Treatment for Primary Biliary Cholangitis

    Author:
    Megan Brooks
    Publish date: June 14, 2024

    Accelerated approval of Iqirvo for PBC was based on data from the phase 3 ELATIVE trial published last year.

    • Read More

    News

    AI Patient Navigator Helps Re-Engage Underserved Patients After Missed Colonoscopy

    Author:
    Megan Brooks
    Publish date: June 13, 2024

    The patient-friendly navigator called patients to discuss rescheduling, assess barriers to colonoscopy uptake, offer live transfers to clinical...

    • Read More

    Audio

    HPV Vaccine Offers Cancer Protection Beyond Cervical Cancer

    Author:
    Megan Brooks
    Publish date: June 11, 2024

    A ‘really important study’ extends the information about the impact of getting vaccinated against HPV, says expert.

    • Read More

    News

    Narcolepsy an Independent Cardiovascular Disease Risk Factor

    Author:
    Megan Brooks
    Publish date: June 11, 2024

    Compared with adults without narcolepsy, those with the chronic sleep disorder had a 77% increased risk for any CVD.

    • Read More

    News

    Red Flags for Early-Onset Colorectal Cancer Identified

    Author:
    Megan Brooks
    Publish date: June 6, 2024

    Hematochezia was the most common presenting sign/symptom, followed by abdominal pain.

    • Read More

    News

    Promising Topline Results for Drug to Treat Concomitant Depression and Insomnia

    Author:
    Megan Brooks
    Publish date: May 31, 2024

    Seltorexant is an investigational potential first-in-class selective antagonist of the human orexin 2 receptor.

    • Read More

    News

    ADCs for Breast Cancer: Clear Benefits, Manageable Risks

    Author:
    Megan Brooks
    Publish date: May 31, 2024

    The latest data on several ADCs — their clinical benefit and safety — were the focus of three presentations at the ESMO Breast Cancer Annual...

    • Read More

    News

    Roche Blood Test for Lp(a) Designated Breakthrough Device

    Author:
    Megan Brooks
    Publish date: May 30, 2024

    Device intended to identify adults with elevated Lp(a) levels, and who may benefit from therapy, is granted breakthrough status.

    • Read More

    News

    Exercise Improves Sexual Health in Women With Metastatic Breast Cancer

    Author:
    Megan Brooks
    Publish date: May 30, 2024

    Physical activity improved sexual health, fatigue, and quality of life.

    • Read More

    News

    Is Vaginal Estrogen Safe in Breast Cancer Survivors?

    Author:
    Megan Brooks
    Publish date: May 24, 2024

    Study results suggest that estrogen therapy “is safe in individuals with HR-negative tumors and in those concurrently treated with tamoxifen.”

    • Read More

    News

    Ultraprocessed Foods May Be an Independent Risk Factor for Poor Brain Health

    Author:
    Megan Brooks
    Publish date: May 23, 2024

    Eating more ultraprocessed foods may increase the risk for cognitive decline and stroke, while eating more unprocessed or minimally processed...

    • Read More

    News

    Psychiatric Comorbidity Prevalent in Eating Disorders

    Author:
    Megan Brooks
    Publish date: May 17, 2024

    Identifying comorbid psychiatric disorders should be part of the management of patients with eating disorders.

    • Read More

    News

    FDA OKs First Multitarget Stool RNA Test for CRC Screening

    Author:
    Megan Brooks
    Publish date: May 15, 2024

    The FDA approval was based on results of the CRC-PREVENT trial.

    • Read More

    Pages

    • « first
    • …
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery